Investment Analysts’ Weekly Ratings Updates for Waystar (WAY)

Several brokerages have updated their recommendations and price targets on shares of Waystar (NASDAQ: WAY) in the last few weeks:

• 1/14/2026 – Waystar was given a new $44.00 price target on by analysts at The Goldman Sachs Group, Inc..
• 1/9/2026 – Waystar had its price target lowered by analysts at Citigroup Inc. from $49.00 to $46.00. They now have a “buy” rating on the stock.
• 1/8/2026 – Waystar is now covered by analysts at Wells Fargo & Company. They set an “overweight” rating and a $41.00 price target on the stock.
• 1/8/2026 – Waystar is now covered by analysts at Wells Fargo & Company. They set an “overweight” rating and a $41.00 price target on the stock.
• 1/1/2026 – Waystar was downgraded by analysts at Zacks Research from a “strong-buy” rating to a “hold” rating.
• 12/15/2025 – Waystar is now covered by analysts at UBS Group AG. They set a “buy” rating and a $41.00 price target on the stock.
• 12/15/2025 – Waystar is now covered by analysts at UBS Group AG. They set a “buy” rating and a $41.00 price target on the stock.
• 12/8/2025 – Waystar had its price target lowered by analysts at Barclays PLC from $56.00 to $42.00. They now have an “overweight” rating on the stock.
• 11/29/2025 – Waystar was downgraded by analysts at Wall Street Zen from a “buy” rating to a “hold” rating.

Insider Activity at Waystar

In other Waystar news, CTO Christopher L. Schremser sold 8,623 shares of the firm’s stock in a transaction that occurred on Wednesday, December 10th. The shares were sold at an average price of $30.41, for a total transaction of $262,225.43. Following the completion of the transaction, the chief technology officer owned 422,371 shares of the company’s stock, valued at approximately $12,844,302.11. This trade represents a 2.00% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Eric L. (Ric) Sinclair III sold 9,701 shares of the firm’s stock in a transaction that occurred on Monday, December 22nd. The shares were sold at an average price of $32.82, for a total value of $318,386.82. Following the transaction, the insider directly owned 474,826 shares of the company’s stock, valued at approximately $15,583,789.32. This trade represents a 2.00% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 40,048 shares of company stock worth $1,360,029 over the last ninety days. 4.10% of the stock is owned by corporate insiders.

Waystar (NASDAQ:WAY) is a leading provider of cloud-based revenue cycle management and payment solutions for healthcare organizations. The company’s unified platform streamlines the entire financial continuum of patient care, from eligibility verification and claim submission to payment reconciliation and patient billing. By automating key processes and improving claim accuracy, Waystar helps providers reduce administrative overhead, accelerate cash flow and enhance overall revenue performance.

At the core of Waystar’s offering is a SaaS-based architecture that integrates seamlessly with existing electronic health record (EHR) systems and payer networks.